Hypoxia selectively upregulates cation channels and increases cytosolic [Ca(2+)] in pulmonary, but not coronary, arterial smooth muscle cells
In the ATTAIN-1 trial, adverse events led to treatment discontinuation in up to 10.3 percent of patients on the drug, compared to only 2.7 percent on placebo
clinical data is demonstrating their efficacy in treating fatty liver disease, cardiovascular conditions, and neurological disorders
Driven by extensive research and inspired by pioneering scientists, Altrient now offers a range of high-performance supplements, including vitamin C, B vitamins, glutathione, and more, providing superior bioavailability to help you achieve optimal health and vitality